Stockscreener 앱 받기
7.27
2.11%
0.15
시간 외 거래:
7.26
-0.010
-0.14%
전일 마감가:
$7.12
열려 있는:
$7.11
하루 거래량:
151.19K
Relative Volume:
0.52
시가총액:
$362.41M
수익:
$13.55M
순이익/손실:
$-25.32M
주가수익비율:
-13.41
EPS:
-0.542
순현금흐름:
-
1주 성능:
+2.83%
1개월 성능:
+16.32%
6개월 성능:
+33.52%
1년 성능:
+0.00%
1일 변동 폭
$6.67
$7.65
1주일 범위
$6.59
$7.65
52주 변동 폭
$3.4341
$15.37
Capsovision Inc Stock (CV) Company Profile
명칭
Capsovision Inc
전화
(408) 370-4790
주소
18805 COX AVENUE SUITE 250, SARATOGA
Compare CV vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CV
Capsovision Inc
|
7.27 | 354.93M | 13.55M | -25.32M | 0 | -0.542 |
ABT
Abbott Laboratories
|
82.56 | 146.87B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
282.58 | 109.33B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
74.54 | 97.77B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
53.37 | 80.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
77.17 | 46.04B | 6.30B | 1.07B | 1.09B | 1.8406 |
Capsovision Inc Stock (CV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-28 | 개시 | Roth Capital | Buy |
| 2025-07-28 | 개시 | The Benchmark Company | Speculative Buy |
Capsovision Inc 주식(CV)의 최신 뉴스
Number of shareholders of CapsoVision, Inc. – NASDAQ:CV - TradingView
Number of shareholders of CapsoVision, Inc. – DUS:H6U - TradingView
Earnings Preview: CapsoVision to Report Financial Results Post-market on May 14 - Moomoo
What makes CapsoVision (CV) different from its competitors? (Breakout Watch) 2026-05-07Social Trade Signals - newser.com
CapsoVision (NASDAQ: CV) amendment reports 5.10M shares owned by Harari group - Stock Titan
CapsoVision (CV) sales head exercises 107,357 options, boosts share stake - Stock Titan
CapsoVision (CV) price target decreased by 16.00% to 10.71 - MSN
CapsoVision to Release First Quarter 2026 Financial Results on May 14, 2026 - GlobeNewswire
CapsoVision (CV) 2026 proxy: director elections, Baker Tilly ratification and pay - Stock Titan
Capsule Endoscope Systems Market Climbs to USD 0.6 Billion - openPR.com
CapsoVision (CV) Stock Outlook | Q4 2025: EPS Tops ViewsShared Momentum Picks - newser.com
CapsoVision targets 510(k) submission for Gen 2 colon capsule and AI module in Q3 2026 as commercial adoption accelerates - MSN
CapsoVision And 2 Other Growth Stocks With Significant Insider Ownership - Yahoo Finance
CV (CapsoVision) reports far narrower Q4 2025 loss than estimates, shares stay flat in today’s trading.Net Margin - Cổng thông tin điện tử Tỉnh Sơn La
[EFFECT] CapsoVision, Inc SEC Filing - Stock Titan
CapsoVision (NASDAQ: CV) registers 2.87M PIPE shares for resale - Stock Titan
CapsoVision (CV) Stock Initiates Position (Froths) 2026-04-18Company Analysis - Cổng thông tin điện tử tỉnh Tây Ninh
CapsoVision (CV) Stock Signal Based Trade (+11.30%) 2026-04-18Stock Distribution - Cổng thông tin điện tử Tỉnh Sơn La
Capsovision Incfiles prospectus for resale of 2,867,089 common shares by selling stockholdersSEC filing - marketscreener.com
Existing holders of CapsoVision (NASDAQ: CV) register 2.87M PIPE shares for resale - Stock Titan
Ching Hang Shen Net Worth (2026) - GuruFocus
CapsoVision (CV) ownership: Shen Ching Hang holds 6.40M shares, Star One indirect - Stock Titan
CapsoVision, Inc. (NASDAQ:CV) Sees Significant Increase in Short Interest - MarketBeat
CapsoVision Inc PE Ratio (TTM) & PE Ratio (TTM) ChartsCV - GuruFocus
CapsoVision (CV) Schedule 13G/A: CID group, Altenza and individuals report ≤5% holdings - Stock Titan
Is CapsoVision (CV) Stock Attractive Now | Price at $7.32, Down 1.61%Risk Reward Ratio - newser.com
Earnings Preview: CapsoVision to Report Financial Results Post-market on March 26 - Moomoo
CV Stock Analysis: CapsoVision Inc. medtech logs double digit daily gain at 7.44 - Cổng thông tin điện tử tỉnh Lào Cai
CV Stock Analysis: CapsoVision Inc Falls 8.78 Percent to Close at 6.65 a Share - newser.com
Major CapsoVision (CV) holder Shen Ching Hang reports large direct and indirect stake - Stock Titan
Short Interest in CapsoVision, Inc. (NASDAQ:CV) Grows By 35.2% - MarketBeat
Benchmark cuts CapsoVision stock price target to $10 on delayed timeline By Investing.com - Investing.com Australia
Benchmark cuts CapsoVision stock price target to $10 on delayed timeline - Investing.com Australia
CapsoVision (NASDAQ:CV) Price Target Lowered to $10.00 at Benchmark - MarketBeat
CapsoVision 2025 Financial Performance Review - AlphaStreet
CapsoVision revenue up 13% to USD 3.9M in Q4 2025 - Medical Buyer
CapsoVision’s CapsoCam: 360° Panoramic AI-Powered Capsule Endoscopy Solution Expanding Global GI Diagnostics Market 2324323344 - Minichart
Large CapsoVision (CV) holder discloses direct and trust share stakes - Stock Titan
CapsoVision Q4 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: CapsoVision Q4 2025 sees revenue growth, stock dips - Investing.com Australia
CapsoVision Q4 Earnings Call Highlights - MarketBeat
Earnings call transcript: CapsoVision Q4 2025 sees revenue growth, stock dips By Investing.com - Investing.com South Africa
CapsoVision Inc reports results for the quarter ended September 30Earnings Summary - TradingView
CapsoVision Reports Fourth Quarter and Full Year 2025 Financial Results - Bitget
CV: AI-powered capsule endoscopy drives growth and innovation in noninvasive GI screening - TradingView
CapsoVision 10-K: Revenue $13.6M, EPS $(1.03) — Annual Results - TradingView
CapsoVision (NASDAQ: CV) flags going concern while advancing AI colon capsule - Stock Titan
Capsovision Inc (CV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.34%
자본화:
|
볼륨(24시간):